Ranbaxy, Teva To Appeal Injunction Against Accupril Generics
Indian drug maker Ranbaxy Laboratories Ltd. and Israeli partner Teva Pharmaceuticals have vowed to file an immediate appeal of a New Jersey federal court's preliminary injunction against sales of a generic...To view the full article, register now.
Already a subscriber? Click here to view full article